Please login to the form below

Not currently logged in
Email:
Password:

diabetes alliance

This page shows the latest diabetes alliance news and features for those working in and with pharma, biotech and healthcare.

Merck & Co and Pfizer take aim at diabetes with trio of new drugs

Merck & Co and Pfizer take aim at diabetes with trio of new drugs

Merck &Co and Pfizer take aim at diabetes with trio of new drugs. ... File ertugliflozin-based products with EU and US regulators. Merck &Co and Pfizer's four-year-old alliance in diabetes has reached fruition with the filing of three new products based

Latest news

  • IBM adds to healthcare capabilities with Truven buy IBM adds to healthcare capabilities with Truven buy

    That approach has already won Watson Health some partnerships with pharma companies, including a project with Novo Nordisk on a digital platform to help manage diabetes, an eHealth alliance with Teva

  • J&J and Hanmi collaborate on diabetes and obesity J&J and Hanmi collaborate on diabetes and obesity

    J&J and Hanmi collaborate on diabetes and obesity. Alliance worth up to$915m. ... Johnson and Johnson have entered into an alliance with Hanmi Pharmaceuticals to develop new treatments for diabetes and obesity.

  • FDA clears Jardiance combo for type 2 diabetes FDA clears Jardiance combo for type 2 diabetes

    FDA clears Jardiance combo for type 2 diabetes. Combination treatment Synjardy is fifth drug to come from Boehringer/Lilly diabetes alliance. ... Synjardy is the fifth FDA-approved medicine to emerge from the Boehringer/Lilly diabetes alliance pipeline

  • Medtronic and Samsung partner on diabetes device Medtronic and Samsung partner on diabetes device

    Medtronic and Samsung partner on diabetes device. Alliance will develop app to monitor glucose and insulin information. ... Announced at the American Diabetes Association's 75th Scientific Sessions, the alliance will utilise Samsung's knowledge of

  • AstraZeneca and its diabetes plans AstraZeneca and its diabetes plans

    Both AZ and BMS had been involved in a diabetes alliance since 2007 and have developed the DPP-4 inhibitor Onglyza (saxagliptin), the saxagliptin/metformin combination product Kombiglyze and the SGLT2 ... This was then expanded in 2012 when the alliance

More from news
Approximately 1 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Pharma deals during June 2014 Pharma deals during June 2014

    It was a busy month for Medtronic as the company also announced the signature of a memorandum of understanding with Sanofi to enter into a global strategic alliance in diabetes. ... It is intended to base the alliance on an open innovation model with

  • Interview: Christopher Boulton, AstraZeneca Interview: Christopher Boulton, AstraZeneca

    This was then expanded in 2012 when the alliance acquired Amylin, gaining the rights to a portfolio of products for type 2 diabetes, including the exenatide franchise (Byetta and Bydureon). ... The recent development with the BMS alliance confirms AZ's

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Virgo Health names US head Virgo Health names US head

    This includes the diabetes alliance between Boehringer Ingelhiem and Lilly, as well as Merck's respiratory portfolio. “

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics